English – Page 186 – TechStock²

Home Depot Stock (HD) News Today: Price, 2026 Outlook, Analyst Forecasts, and Key Risks as of December 20, 2025

Home Depot, Inc. (NYSE: HD) heads into the final stretch of 2025 with investors weighing a cautious company outlook, a still-choppy U.S. housing backdrop, and a steady stream of analyst revisions following its December investor conference. The stock ended the

20 December 2025

Financial Analysis·Home Depot·Investing·Market Forecasts·NYSE:HD·Stock Market

Alnylam Pharmaceuticals (ALNY) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025

As of Saturday, December 20, 2025, investors are digesting a busy stretch of developments around Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)—from Nasdaq-100 index inclusion (effective Dec. 22) to fresh reimbursement tailwinds in the U.K. and continued focus on Amvuttra (vutrisiran) as

20 December 2025

Analyst Opinions·Biotech Stocks·Financial Forecasts·Investment Analysis·NASDAQ:ALNY·Stock Market News

Qualcomm Stock (QCOM) News, Forecasts and Analysis for December 20, 2025: Alphawave Semi Deal, Insider Sales, and the 2026 Outlook

December 20, 2025 — With U.S. markets closed for the weekend, the latest read on QUALCOMM Incorporated (NASDAQ: QCOM) comes from Friday’s session: QCOM last closed at $175.25 and traded modestly higher in after-hours. StockAnalysis That price point sits at

20 December 2025

Financial News·Investment Analysis·NASDAQ:QCOM·Semiconductor Industry·Stock Market·Technology

Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts

December 20, 2025 — Amgen Inc. (NASDAQ: AMGN) is closing out the year with a rare combination of near-term policy headlines and company-specific catalysts that matter to investors: a new U.S. drug-pricing deal tied to the TrumpRx rollout, fresh FDA

20 December 2025

Dividend Updates·FDA Approvals·Investment Analysis·NASDAQ:AMGN·Pharmaceuticals·Stock Market News

Johnson & Johnson Stock JNJ: Talc Verdict, Drug Pricing Pressure, and the 2026 Forecast as of Dec. 20, 2025

Dec. 20, 2025 — Johnson & Johnson (NYSE: JNJ) is closing out the week with investors weighing a fresh talc-related jury verdict, a fast-moving U.S. drug-pricing policy push that could soon reach J&J, and a stream of late-2025 catalysts spanning

20 December 2025

Healthcare Industry·Legal News·Market Forecasts·NYSE:JNJ·Pharmaceuticals·Stock Analysis

Monolithic Power Systems, Inc. (MPWR) Stock: Nasdaq-100 Addition, Dividend Update, and Fresh Analyst Forecasts as AI Data-Center Demand Builds

Dec. 20, 2025 — Monolithic Power Systems, Inc. (NASDAQ: MPWR) is ending 2025 in the spotlight after a cluster of catalysts that tends to matter for momentum-driven and fundamentals-driven investors alike: the stock is set to join the Nasdaq-100, the

20 December 2025

AI Trends·Dividend Updates·Investment News·Stock Market·Technology Stocks

Exxon Mobil Stock (XOM) Today: 2030 Plan Upgrade, Buyback Outlook and Analyst Forecasts as Oil Slips Below $60

Date: December 20, 2025 Exxon Mobil Corporation (NYSE: XOM) heads into the final stretch of 2025 with a familiar mix of forces shaping its share price: weakening crude prices, a heavy focus on low-cost production growth (especially the Permian Basin

20 December 2025

Analyst Forecasts·Financial News·Investment Strategies·Oil Industry·Stock Market

Salesforce (CRM) Stock News and Forecasts on Dec. 20, 2025: Agentforce AI Momentum, Qualified Acquisition, and Wall Street Price Targets

December 20, 2025 — Salesforce, Inc. (NYSE: CRM) stock is heading into the final stretch of 2025 at the center of a debate investors know well: is this a beaten-down software leader becoming a bargain again, or a “value trap”

20 December 2025

AI Technology·Financial Forecasts·Investment Analysis·NYSE:CRM·Salesforce News·Stock Market

AppLovin (APP) Stock Update Dec. 20, 2025: Why Shares Are Surging, Fresh Analyst Targets, and the Next Catalysts

AppLovin Corporation (NASDAQ: APP) has become one of the market’s most closely watched adtech and AI-driven marketing stories—especially as investors debate how much runway remains in its e-commerce expansion and how durable its mobile gaming advertising strength will be into

20 December 2025

Analyst Ratings·Financial Updates·Investment Analysis·NASDAQ:APP·Stock Market News·Tech Stocks

CoreWeave (CRWV) Stock News and Forecasts for Dec. 20, 2025: DOE “Genesis Mission” Boosts Shares as Analysts Debate AI Data-Center Risks

CoreWeave, Inc. (NASDAQ: CRWV) ends the week back in the spotlight after a sharp Friday rebound that partially reversed a bruising late-2025 selloff. As of the Dec. 19, 2025 close (the last trading session ahead of Dec. 20), CoreWeave shares

20 December 2025

AI Technology·Data Centers·Financial Forecasts·Investment Analysis·Stock Market News

Lamb Weston (LW) Stock Plunges After Earnings Beat: Margin Pressure, 2026 Outlook, and Analyst Forecasts as of Dec. 20, 2025

Lamb Weston Holdings, Inc. (NYSE: LW) is back in the market’s spotlight this weekend—and not because investors suddenly stopped liking French fries. After reporting second-quarter fiscal 2026 results that beat Wall Street expectations on revenue and adjusted earnings, Lamb Weston

20 December 2025

Company News·Earnings Reports·Financial Forecasts·Investment Analysis·NYSE:LW·Stock Market

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine, Inc. (NASDAQ: IRON) stock is seeing a classic “biotech catalyst storm” on Dec. 20, 2025: big intraday swings, headline-driven volatility, and analysts arguing over whether the market is repricing risk or merely repricing uncertainty. As of the latest

20 December 2025

Biotech Stocks·FDA Updates·Financial Forecasts·Investment Analysis·NASDAQ:IRON·Stock Market News